Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation in CKD Progression
NCT04361097Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Aug 2018
- Primary completion
- Nov 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in chronic kidney disease (CKD) (2 arms), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Creatinine Clearance at 6 months. Started Aug 2018; status: completed.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04361097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361097.